We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Tribunal decision.
What sites are collection centres, the animal by-products (ABPs) you can treat at one, and how you must treat them.
Evidence-based recommendations to protect first responders from exposure to fentanyl.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Recordati Rare Diseases T/A Recordati Rare Diseases UK Ltd has made the MHRA aware that specific batches of Pedea 5 mg/ml solution for injection have been packaged with the incorrect Product Information Leaflet (PIL).
A European review has considered MHRA evidence together with additional information from spontaneous reporting and published literature.
Use a filter needle when drawing up reconstituted dantrolene solution.
Product recall for Surf System Wetsuit Shampoo presenting a chemical risk.
This publication is intended for Valuation Officers. It may contain links to internal resources that are not available through this version.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
Information on formaldehyde (also known as methanal and methylene glycol) for use in responding to chemical incidents.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
Accord Healthcare Ltd, UK has informed the MHRA about an error with the Patient Information Leaflets (PILs) that have been packaged in the batches of these products mentioned in this notification.
Information on ammonia (also known as hydrogen nitride), for use in responding to chemical incidents.
A summary of letters and recent medicine recalls and notifications sent to healthcare professionals.
Since November 2014, letters were sent regarding vismodegib (Erivedge ▼), chlorhexidine solutions, carbocisteine oral liquid (Mucodyne Paediatric 125mg/5ml), regadenoson (Rapiscan), a parenteral nutrition emulsion (Triomel), and telavancin (Vibativ▼).
Sanofi UK is initiating an urgent recall of two batches of Targocid 200mg powder for solution for injection/infusion or oral solution
Reports of reconstituted solution leaking from some models of extension sets and pumps.…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).